Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harsh Golwala

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Lung India : Official Organ of Indian Chest Society|February 21, 2012
Marijuana abuse and bullous emphysemaHarsh Golwala
Journal of the American College of Cardiology|July 26, 2014
In regard to the TERISA trialHarsh Golwala
The New England Journal of Medicine|October 18, 2013
Device surgery without interruption of anticoagulationHarsh Golwala
Journal of the American College of Cardiology|September 10, 2013
Enalapril/carvedilol for prevention of chemotherapy-induced heart failure: an end to the problemHarsh Golwala
European Heart Journal. Quality of Care & Clinical Outcomes|January 9, 2020
Lowering inflammation through lipid-lowering therapy: are we there yet?Nayan Agarwal, Harsh Golwala
The American Journal of Medicine|February 24, 2022
Antiplatelet Agents in Acute ST Elevation Myocardial InfarctionKris Kumar, Harsh Golwala
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2011
Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: a case report and review of the literatureHarsh Golwala, Tarek Dernaika
JACC. Cardiovascular Interventions|June 9, 2023
Bioprosthetic Valve Remodeling in Transcatheter Aortic Valve-in-Valve Replacement: From Bench Testing to Clinical ImplicationsFiras Zahr, Harsh Golwala
European Heart Journal. Quality of Care & Clinical Outcomes|January 8, 2021
Chained to the rhythm: breaking free from pacemaker requirements following transcatheter aortic valve replacementAndrew M Goldsweig, Harsh Golwala
Progress in Cardiovascular Diseases|January 18, 2018
The Timing of P2Y<sub>12</sub> Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?Harsh Golwala, Deepak L Bhatt
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Lung India : Official Organ of Indian Chest Society|February 21, 2012
Marijuana abuse and bullous emphysemaHarsh Golwala
Journal of the American College of Cardiology|July 26, 2014
In regard to the TERISA trialHarsh Golwala
The New England Journal of Medicine|October 18, 2013
Device surgery without interruption of anticoagulationHarsh Golwala
Journal of the American College of Cardiology|September 10, 2013
Enalapril/carvedilol for prevention of chemotherapy-induced heart failure: an end to the problemHarsh Golwala
European Heart Journal. Quality of Care & Clinical Outcomes|January 9, 2020
Lowering inflammation through lipid-lowering therapy: are we there yet?Nayan Agarwal, Harsh Golwala
The American Journal of Medicine|February 24, 2022
Antiplatelet Agents in Acute ST Elevation Myocardial InfarctionKris Kumar, Harsh Golwala
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2011
Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: a case report and review of the literatureHarsh Golwala, Tarek Dernaika
JACC. Cardiovascular Interventions|June 9, 2023
Bioprosthetic Valve Remodeling in Transcatheter Aortic Valve-in-Valve Replacement: From Bench Testing to Clinical ImplicationsFiras Zahr, Harsh Golwala
European Heart Journal. Quality of Care & Clinical Outcomes|January 8, 2021
Chained to the rhythm: breaking free from pacemaker requirements following transcatheter aortic valve replacementAndrew M Goldsweig, Harsh Golwala
Progress in Cardiovascular Diseases|January 18, 2018
The Timing of P2Y<sub>12</sub> Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?Harsh Golwala, Deepak L Bhatt
Pageof 10